爱朋医疗
(300753)
| 流通市值：19.49亿 | | | 总市值：29.80亿 |
| 流通股本：8243.36万 | | | 总股本：1.26亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 64,821,886.38 | 403,802,245.57 | 274,753,514.1 | 179,465,240.74 |
| 营业收入 | 64,821,886.38 | 403,802,245.57 | 274,753,514.1 | 179,465,240.74 |
| 二、营业总成本 | 86,653,651.22 | 398,548,720.03 | 271,029,178.03 | 176,068,376.14 |
| 营业成本 | 24,692,282.96 | 127,529,963.71 | 85,112,978.52 | 57,082,893.49 |
| 税金及附加 | 998,934.32 | 4,989,594.26 | 3,472,498.02 | 1,928,063.95 |
| 销售费用 | 35,058,141.07 | 154,030,675.93 | 100,705,131.68 | 59,739,038.78 |
| 管理费用 | 16,357,440.28 | 77,580,543.56 | 57,431,028.93 | 40,880,017.36 |
| 研发费用 | 8,829,562.22 | 33,277,595.24 | 23,409,768.84 | 15,740,917.42 |
| 财务费用 | 717,290.37 | 1,140,347.33 | 897,772.04 | 697,445.14 |
| 其中:利息费用 | 776,088.59 | 3,066,381.22 | 2,269,106.8 | 680,826.82 |
| 其中:利息收入 | 75,178.74 | 1,982,976.77 | 1,419,121.75 | 828,639.57 |
| 加:投资收益 | 683,600.98 | -1,384,285.52 | -598,285.1 | -535,151.2 |
| 资产处置收益 | - | 3,589,227.98 | 3,643,568.78 | 3,526,417.61 |
| 资产减值损失(新) | -273,816.71 | -585,189.23 | -113,597.17 | 192,421.79 |
| 信用减值损失(新) | -1,473,721.39 | -5,830,218.61 | -3,110,332.15 | 605,672.29 |
| 其他收益 | 2,793,362.44 | 22,443,958.12 | 9,428,807.57 | 8,180,424.86 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -20,102,339.52 | 23,487,018.28 | 12,974,498 | 15,366,649.95 |
| 加:营业外收入 | 3,601.15 | 345.65 | 941.14 | 565.37 |
| 减:营业外支出 | 455,460.13 | 2,320,325.06 | 2,476,736.18 | 2,078,681.4 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -20,554,198.5 | 21,167,038.87 | 10,498,702.96 | 13,288,533.92 |
| 减:所得税费用 | -1,983,769.02 | 10,272,207.14 | 6,626,807.72 | 4,490,921.39 |
| 六、净利润 | -18,570,429.48 | 10,894,831.73 | 3,871,895.24 | 8,797,612.53 |
| 持续经营净利润 | -18,570,429.48 | 10,894,831.73 | 3,871,895.24 | 8,797,612.53 |
| 归属于母公司股东的净利润 | -17,649,164.17 | 10,800,733.83 | 3,807,308.09 | 8,893,500.73 |
| 少数股东损益 | -921,265.31 | 94,097.9 | 64,587.15 | -95,888.2 |
| (一)基本每股收益 | -0.14 | 0.09 | 0.03 | 0.07 |
| (二)稀释每股收益 | -0.14 | 0.09 | 0.03 | 0.07 |
| 九、综合收益总额 | -18,570,429.48 | 10,894,831.73 | 3,871,895.24 | 8,797,612.53 |
| 归属于母公司股东的综合收益总额 | -17,649,164.17 | 10,800,733.83 | 3,807,308.09 | 8,893,500.73 |
| 归属于少数股东的综合收益总额 | -921,265.31 | 94,097.9 | 64,587.15 | -95,888.2 |
| 公告日期 | 2025-04-29 | 2025-04-19 | 2024-10-30 | 2024-08-17 |
| 审计意见(境内) | | 标准无保留意见 | | |